Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...

A New Orleans-based biotech company has developed a breakthrough non-opioid pain medication, which is backed by funding from Ochsner Ventures, the investment arm of Ochsner Health, and from Gulf South ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. The Food and Drug Administration on Wednesday issued ...

For the last quarter century, one of the world’s most capable drug developers toiled to make a new, non-addictive kind of painkiller. The journey was fittingly excruciating. Pain, as Vertex ...

Plans to seek regulatory approval to commence a Phase III trial in the US and Canada VANCOUVER, BC, Jan. 8, 2026 /PRNewswire/ -- Sustained Therapeutics Inc. ("Sustained Therapeutics" or the "Company") ...

Prescriptions for the new non-opioid pain medication suzetrigine more than doubled between April and August 2025, according to analysis from Epic Research. The increase indicates a growing interest in ...

America has a chronic pain problem. While there has been increased attention, in both policy and drug development, on non-opioid treatments, the focus has been on managing acute pain. The current ...

The number of surgeries in the United States rises each year, with over 92 million performed in 2024. 1 For many patients, surgery is only half the battle. Managing pain afterward is often the greater ...

Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and ...

How does your doctor actually prescribe opioid medication? Why is it hard to get a refill? What are the best solutions to ...